
Glaukos rose 170.2% from $88.35 to $238.74, ahead of the S&P 500's +10.5%. Its worst day was May 22 (−13.5%), and its low came Nov 10 at $88.35.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.28 missed the $-0.21 estimate on $143.1M revenue (est. $137.9M); FY revenue guidance of $600.0M–$620.0M against the $569.4M consensus.
+13.5% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
EPS of $-0.18 beat the $-0.28 estimate on $150.6M revenue (est. $137.0M); FY revenue guidance of $620.0M–$635.0M against the $613.7M consensus.
+22.8% · S&P 500 +1.0%
Glaukos shares fell 13.5%, while the S&P 500 rose 0.4%.
−13.5%, the year's worst day · S&P 500 +0.4%
EPS of $-0.14 beat the $-0.23 estimate on $185.6M revenue (est. $150.7M); FY revenue guidance of $680.0M–$700.0M against the $630.0M consensus.
+4.2% · S&P 500 +1.7%
EPS of $0.47 beat the $-0.10 estimate on $211.0M revenue (est. $168.2M); FY revenue guidance of $1.0B against the $849.0M consensus.
+33.6%, the year's best day · S&P 500 −0.4%
Where it ended: a close of $238.74 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 16, 2027 (EPS est. $0.45, revenue est. $231.7M).
Nothing in the past 12 months.
All GKOS dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GKOS and SPY from Benzinga historical bars. Not investment advice.